KEYNOTE-905 (EV-303) Peri-operative pembrolizumab + enfortumab vedotin in muscle-invasive bladder cancer | Dr Dilanka De Silva
Who should read this? People with muscle-invasive bladder cancer (MIBC) who are not eligible for cisplatin chemotherapy, or who have […]